Erratum to: Sunitinib Possible Sex-Divergent Therapeutic Outcomes.

Section 4, 4th paragraph, 1st sentence, which previously read: The lower sunitinib hepatic exposure in female mice may anticipate both, the lesser susceptibility to toxicity observed of male patients [32], and the higher incidence (p = 0.016) of C3 grade adverse events [14, 15] and risk (p = 0.04) of thrombocytopenia [16] in female patients. Should read: The lower sunitinib hepatic exposure in male mice may anticipate both, the lesser susceptibility to toxicity observed of male patients [32], and the higher incidence (p = 0.016) of C3 grade adverse events [14, 15] and risk (p = 0.04) of thrombocytopenia [16] in female patients.